These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35565912)

  • 1. Diet Quality and Dietary Inflammatory Index in Dutch Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients.
    de Graaf MCG; Spooren CEGM; Hendrix EMB; Hesselink MAM; Feskens EJM; Smolinska A; Keszthelyi D; Pierik MJ; Mujagic Z; Jonkers DMAE
    Nutrients; 2022 May; 14(9):. PubMed ID: 35565912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Intake of Dicarbonyls and Advanced Glycation Endproducts as Part of the Habitual Diet Is Not Associated with Intestinal Inflammation in Inflammatory Bowel Disease and Irritable Bowel Syndrome Patients.
    de Graaf MCG; Scheijen JLJM; Spooren CEGM; Mujagic Z; Pierik MJ; Feskens EJM; Keszthelyi D; Schalkwijk CG; Jonkers DMAE
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
    Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary Patterns in Runners with Gastrointestinal Disorders.
    Erdman KA; Jones KW; Madden RF; Gammack N; Parnell JA
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33572891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anhedonia in irritable bowel syndrome and in inflammatory bowel diseases and its relationship with abdominal pain.
    Carpinelli L; Bucci C; Santonicola A; Zingone F; Ciacci C; Iovino P
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13531. PubMed ID: 30628137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity.
    Berrill JW; Green JT; Hood K; Campbell AK
    Aliment Pharmacol Ther; 2013 Jul; 38(1):44-51. PubMed ID: 23668698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EHealth: self-management in inflammatory bowel disease and in irritable bowel syndrome using novel constant-care web applications. EHealth by constant-care in IBD and IBS.
    Pedersen N
    Dan Med J; 2015 Dec; 62(12):B5168. PubMed ID: 26621403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.
    Maagaard L; Ankersen DV; Végh Z; Burisch J; Jensen L; Pedersen N; Munkholm P
    World J Gastroenterol; 2016 Apr; 22(15):4009-19. PubMed ID: 27099444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease.
    Shutkever O; Gracie DJ; Young C; Wood HM; Taylor M; John Hamlin P; Ford AC; Quirke P
    Inflamm Bowel Dis; 2018 Jun; 24(7):1597-1605. PubMed ID: 29668957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population.
    Lee AD; Spiegel BM; Hays RD; Melmed GY; Bolus R; Khanna D; Khanna PP; Chang L
    Neurogastroenterol Motil; 2017 May; 29(5):. PubMed ID: 27981684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome.
    Guadagnoli L; Mutlu EA; Doerfler B; Ibrahim A; Brenner D; Taft TH
    Qual Life Res; 2019 Aug; 28(8):2195-2205. PubMed ID: 30900206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?].
    Mearin F; Perelló A; Balboa A
    Gastroenterol Hepatol; 2009 May; 32(5):364-72. PubMed ID: 19442413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission.
    Hoekman DR; Zeevenhooven J; D'Haens GR; Benninga MA
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1086-1090. PubMed ID: 28639969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome.
    Chang MH; Chou JW; Chen SM; Tsai MC; Sun YS; Lin CC; Lin CP
    Mol Med Rep; 2014 Jul; 10(1):522-6. PubMed ID: 24788223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
    Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexisting irritable bowel-like symptoms in inflammatory bowel disease in remission is associated with impaired social functioning and increased bodily pain.
    Jelsness-Jørgensen LP; Bernklev T; Moum B
    Gastroenterol Nurs; 2014; 37(4):280-7. PubMed ID: 25078042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
    Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA
    Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Low-FODMAP Diet Provides Benefits for Functional Gastrointestinal Symptoms but Not for Improving Stool Consistency and Mucosal Inflammation in IBD: A Systematic Review and Meta-Analysis.
    Peng Z; Yi J; Liu X
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
    Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.